| AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor J Font de Mora, M Brown Molecular and cellular biology 20 (14), 5041-5047, 2000 | 599 | 2000 |
| IRS-2 pathways integrate female reproduction and energy homeostasis DJ Burks, JF de Mora, M Schubert, DJ Withers, MG Myers, HH Towery, ... Nature 407 (6802), 377-382, 2000 | 561* | 2000 |
| High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene MI Torres-Arzayus, JF de Mora, J Yuan, F Vazquez, R Bronson, M Rue, ... Cancer cell 6 (3), 263-274, 2004 | 450* | 2004 |
| Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation J Font de Mora, A Porras, N Ahn, E Santos Molecular and cellular biology 17 (10), 6068-6075, 1997 | 219 | 1997 |
| Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis C Garcés, MJ Ruiz-Hidalgo, JF de Mora, C Park, L Miele, J Goldstein, ... Journal of Biological Chemistry 272 (47), 29729-29734, 1997 | 191* | 1997 |
| Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis E Fuentes Q, F Fuentes Q, V Andrés, OM Pello, JF de Mora, I Palomo G Platelets 24 (4), 255-262, 2013 | 153 | 2013 |
| Ras‐GRF1 signaling is required for normal β‐cell development and glucose homeostasis JF de Mora, LM Esteban, DJ Burks, A Núñez, C Garcés, ... The EMBO journal, 2003 | 95 | 2003 |
| Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines. C Guerrero, JM Rojas, M Chedid, LM Esteban, DB Zimonjic, NC Popescu, ... Oncogene 12 (5), 1097-1107, 1996 | 83* | 1996 |
| Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas RS Carroll, M Brown, J Zhang, J DiRenzo, J Font De Mora, PML Black Clinical cancer research 6 (9), 3570-3575, 2000 | 82 | 2000 |
| RasGrf1 deficiency delays aging in mice C Borrás, D Monleón, R López-Grueso, J Gambini, L Orlando, ... Aging (albany NY) 3 (3), 262, 2011 | 74 | 2011 |
| Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor B Hämmerle, Y Yañez, S Palanca, A Cañete, DJ Burks, V Castel, ... PloS one 8 (10), e76761, 2013 | 67 | 2013 |
| GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase B Perez-Benavente, JL García, MS Rodriguez, A Pineda-Lucena, ... Oncogene 32 (17), 2189-2199, 2013 | 60 | 2013 |
| miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis P Berlanga, L Muñoz, M Piqueras, JA Sirerol, MD Sánchez-Izquierdo, ... Molecular oncology 10 (7), 1043-1053, 2016 | 51 | 2016 |
| Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: a proof of concept SIOPEN study‖ M Morini, D Cangelosi, D Segalerba, D Marimpietri, F Raggi, A Castellano, ... Cancers 11 (10), 1476, 2019 | 50 | 2019 |
| Deletion of 11q in neuroblastomas drives sensitivity to PARP inhibition. E Sanmartín, L Muñoz, M Piqueras, JA Sirerol, P Berlanga, A Cañete, ... Clinical Cancer Research, 2017 | 43 | 2017 |
| Transformation suppressor activity of C3G is independent of its CDC25-homology domain C Guerrero, A Fernandez-Medarde, JM Rojas, J Font de Mora, ... Oncogene 16 (5), 613-624, 1998 | 41 | 1998 |
| Structural organization of the components of the cell wall from Candida albicans J Ruiz-Herrera, S Mormeneo, P Vanaclocha, J Font-De-Mora, M Iranzo, ... Microbiology 140 (7), 1513-1523, 1994 | 40 | 1994 |
| Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR … A Bellini, U Pötschger, V Bernard, E Lapouble, S Baulande, PF Ambros, ... Journal of Clinical Oncology 39 (30), 3377-3390, 2021 | 37 | 2021 |
| Moderate overexpression of AIB1 triggers pre-neoplastic changes in mammary epithelium Á Avivar, MC García-Macias, E Ascaso, G Herrera, JE O’Connor, ... FEBS letters 580 (22), 5222-5226, 2006 | 37 | 2006 |
| Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value G Reynes, V Vila, T Fleitas, E Reganon, J Font de Mora, M Jordá, ... PloS one 8 (7), e69034, 2013 | 36* | 2013 |
